| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10060818 | HBV | ENSG00000109072.14 | protein_coding | VTN | No | No | 7448 | D9ZGG2 P04004 |
| TVIS10059157 | HBV | ENSG00000109072.14 | protein_coding | VTN | No | No | 7448 | D9ZGG2 P04004 |
| TVIS10059161 | HBV | ENSG00000109072.14 | protein_coding | VTN | No | No | 7448 | D9ZGG2 P04004 |
| TVIS10060129 | HBV | ENSG00000109072.14 | protein_coding | VTN | No | No | 7448 | D9ZGG2 P04004 |
| TVIS10059160 | HBV | ENSG00000109072.14 | protein_coding | VTN | No | No | 7448 | D9ZGG2 P04004 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | VTN |
|---|---|
| DrugBank ID | DB00054 |
| Drug Name | Abciximab |
| Target ID | BE0001068 |
| UniProt ID | P04004 |
| Regulation Type | |
| PubMed IDs | 17160551; 12749745 |
| Citations | Romagnoli E, Burzotta F, Trani C, Biondi-Zoccai GG, Giannico F, Crea F: Rationale for intracoronary administration of abciximab. J Thromb Thrombolysis. 2007 Feb;23(1):57-63.@@Ibbotson T, McGavin JK, Goa KL: Abciximab: an updated review of its therapeutic use in patients with ischaemic heart disease undergoing percutaneous coronary revascularisation. Drugs. 2003;63(11):1121-63. |
| Groups | Approved |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | Abciximab Action Pathway |
| PharmGKB | PA448006 |
| ChEMBL | CHEMBL1201584 |
